Company / Operating Cash Flow per Share
Progyny Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$2.46
FY2025
5-year range
$0.26 / $2.46
FY2021-FY2025
Trend
+32.5%
vs FY2024
Sector context
#80 of 155
Health Care
What the data says
At $2.46, Progyny's operating cash flow per share ranks #80 of 155 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 9 years, ranging from $-1.67 in FY2017 to $2.46 in FY2025.
Based on SEC 10-K filings.
2.46 in FY2025 with a 5-year CAGR of +46.5%.
Improved from $2.02 to $2.46 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +40.8%
- 5-Year CAGR
- +46.5%
- 10-Year CAGR
- -
Sector benchmark
#80 of 155 in Health CareTop 52% of 155This company $2.46 Sector average $6.77
▼
-63.6% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 32.5% year-over-year.
- Ranks #80 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.46 | +32.5% |
| FY2024 | $1.86 | -8.1% |
| FY2023 | $2.02 | +129.3% |
| FY2022 | $0.88 | +240.2% |
| FY2021 | $0.26 | -29.0% |
| FY2020 | $0.37 | +594.0% |
| FY2019 | -$0.07 | -118.0% |
| FY2018 | $0.41 | +124.6% |
| FY2017 | -$1.67 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026